Content about Medicis Pharmaceutical

September 4, 2012

Canadian drug maker Valeant Pharmaceuticals International is buying Medicis Pharmaceutical for $2.6 billion, Valeant said Monday.

March 27, 2012

Hyperion Therapeutics has purchased rights to a drug for treating genetic metabolic disorders, the company said.

© 2014 Drug Store News. All Rights Reserved.